MONOLONG 60 MG

Valsts: Izraēla

Valoda: angļu

Klimata pārmaiņas: Ministry of Health

Nopērc to tagad

Lietošanas instrukcija Lietošanas instrukcija (PIL)
17-08-2016

Aktīvā sastāvdaļa:

ISOSORBIDE-5-MONONITRATE

Pieejams no:

CTS CHEMICAL INDUSTRIES LTD

ATĶ kods:

C01DA14

Zāļu forma:

CAPSULES SLOW RELEASE

Kompozīcija:

ISOSORBIDE-5-MONONITRATE 60 MG

Ievadīšanas:

PER OS

Receptes veids:

Required

Ražojis:

CTS CHEMICAL INDUSTRIES LTD

Ārstniecības grupa:

ISOSORBIDE MONONITRATE

Ārstniecības joma:

ISOSORBIDE MONONITRATE

Ārstēšanas norādes:

Prevention and treatment of angina pectoris.

Autorizācija datums:

2011-02-28

Lietošanas instrukcija

                                PATIENT LEAFLET AS PER THE PHARMACISTS’ REGULATIONS
(PRODUCTS) - 1986
Prescription only medicine
READ THE ENTIRE LEAFLET CAREFULLY BEFORE COMMENCING TREATMENT
THE FORMAT OF THIS LEAFLET WAS DETERMINED BY THE MINISTRY OF HEALTH
AND ITS CONTENT WAS CHECKED AND APPROVED IN FEBRUARY 2006
MONOLONG
® 40
MONOLONG
® 60
Sustained-Release Capsules
Sustained-Release Capsules
COMPOSITION:
Each sustained-release
Each sustained-release
capsule contains:
capsule contains:
Isosorbide Mononitrate 40 mg
Isosorbide Mononitrate 60 mg
Also contains: 81.75 mg sugar
Also contains: 122.61 mg sugar
And also: Lactose, sucrose, shellac, maize starch, purified talc,
eudragit L-100,
eudragit RS-100.
THERAPEUTIC GROUP: Nitrates.
THERAPEUTIC ACTION: For the prevention of angina pectoris.
WHEN SHOULD THE PRODUCT NOT BE USED?
Do not use if you are hypersensitive to one of its ingredients or to
other
medications of the nitrates group.
Do not use this medicine concomitantly with a product containing
sildenafil
(Viagra) in view of the severe side effects that may occur (such as:
fainting,
myocardial infarction).
This preparation is not intended for the relief of acute attack of
angina pectoris.
THIS MEDICINE SHOULD NOT BE USED WITHOUT CONSULTING YOUR PHYSICIAN
PRIOR
TO COMMENCING TREATMENT:
If you are pregnant or breastfeeding.
If you suffer or have suffered dysfunction of the: heart (myocardial
infarction),
eyes (e.g. glaucoma), liver, kidneys/urinary system, digestive system
(e.g.
ulcer), thyroid gland, hypotension, cerebral damage, hemorrhage or
disturbance,
low body temperature, severe anemia.
HOW WILL THIS MEDICINE AFFECT YOUR EVERY DAY LIFE?
Wines or alcoholic beverages must not be taken during treatment with
this
medicine.
WARNINGS:
This preparation contains lactose and may cause an allergic reaction
in patients
sensitive to lactose.
During treatment with this medicine, blood pressure tests and liver
function
tests should be performed.
Avoid sudden transition from a lying/sitting position to a standing
position, in
order to avoid dizzine
                                
                                Izlasiet visu dokumentu
                                
                            

Dokumenti citās valodās

Lietošanas instrukcija Lietošanas instrukcija arābu 25-03-2015
Lietošanas instrukcija Lietošanas instrukcija ivrits 17-08-2016

Meklēt brīdinājumus, kas saistīti ar šo produktu

Skatīt dokumentu vēsturi